Docsity
Docsity

Prepare for your exams
Prepare for your exams

Study with the several resources on Docsity


Earn points to download
Earn points to download

Earn points by helping other students or get them with a premium plan


Guidelines and tips
Guidelines and tips

Helicobacter pylori Testing and Eradication: Guidelines for Adults, Lecture notes of History

Guidelines for testing and treating helicobacter pylori (hp) infections in adults. It covers indications for testing, when to start treatment, and recommended eradication regimens. The document also discusses the importance of patient understanding and adherence, as well as potential risks and complications.

What you will learn

  • What are the indications for testing Helicobacter pylori in adults?
  • What is the recommended treatment regimen for Helicobacter pylori in adults?
  • What should be done in cases of eradication failure?

Typology: Lecture notes

2021/2022

Uploaded on 09/12/2022

robinhood05
robinhood05 🇬🇧

4.8

(16)

229 documents

1 / 4

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
H pylo ri testing and eradication for adults
Patients with uncomplicated dyspepsia u nresponsive to lifestyle change and antacids, following a single one month course of proton pump i nhibitor (PPI),
without alarm symptoms. A trial of PPI should usu ally be prescribe d before testing, unless the likelihood of HP is likely to be higher than 20% (older
people, people of North African ethnicity, those living in a known high risk area); in which case the patient should have a test for H. pylori first, or in
parallel with a course of PPI.
Patients with a history of gastric or duodenal ulcer or bleed, if they have not previously been tested.
Before starting or taking NSAIDs, if there is a history of gastro-duodenal ulcers or bleeds. Note that HP a nd NSAIDs are independent risk factors for
peptic ulcers, so eradication will not remove all risk.
Patients with un explained iron-deficiency anaemia, after negati ve endoscopic investigation has excluded gastric and colonic malig nancy, and
investigations have been carried out for other causes, includi ng: cancer, idiopathic thrombocytopenic purpura, vitamin B12 deficiency.
Before stool antigen testing for H pylori, patients should have stopped bismuth or PPI for at least 2 weeks; antibi otics for 4 weeks; and H2 Receptor
Antago nist (H2RA) at least 1 day before, or results may be unreliable
Patients with proven oesophagitis, or predominant symptoms of reflux, suggesting GORD (gastro-oesophageal r eflux disease)
When should I treat Helicobacter pylo ri?
H pylori Positive
H pylori Negative
ASYMPTOMATIC post-HP
treatment
Treat H pylori
If H pylori negative treat as functional dyspepsia.
Step down to lowest dose of PPI or H2RA nee ded
to control symptoms. Review annually, including
PPI need.
Reassure, as
negative
pre dictive val ue
(NPV) of all tests
is >95%
Only retest f or HP if DU, GU,
family history of cancer,
MALToma or if test was
performed within two weeks of
PPI or four weeks of antibiotics
When should I test for Helicoba cter pylori (HP)?
When is a test for Helicobacter pylori not required?
pf3
pf4

Partial preview of the text

Download Helicobacter pylori Testing and Eradication: Guidelines for Adults and more Lecture notes History in PDF only on Docsity!

H pylori testing and eradication for adults

  • Patients with uncomplicated dyspepsia unresponsive to lifestyle change and antacids, following a single one month course of proton pump inhibitor (PP I), without alarm symptoms. A trial of PPI should usually be prescribed before testing, unless the likelihood of HP is likely to be higher than 20% (older people, people of North African ethnicity, those living in a known high risk area); in which case the patient should have a test for H. pylori first, or in parallel with a course of PPI.
  • Patients with a history of gastric or duodenal ulcer or bleed, if they have not previously been tested.
  • Before starting or taking NSAIDs, if there is a history of gastro-duodenal ulcers or bleeds. Note that HP and NSA IDs are independent risk factors for peptic ulcers, so eradication will not remove all risk.
  • Patients with unexplained iron-deficiency anaemia, aft er negative endoscopic investigation has excluded gastric and colonic malignancy, and investigations have been carried out for other causes, including: cancer, idiopat hic thrombocytopenic purpura, vitamin B12 deficiency.
  • Before stool antigen testing for H pylori , patients should have stopped bismuth or PPI for at least 2 weeks ; antibiotics for 4 weeks ; and H 2 Receptor Antagonist (H 2 RA) at least 1 day before, or results may be unreliable
  • Patients with proven oesophagitis, or predominant symptoms of reflux, suggesting GORD (gastro-oesophageal reflux disease)

When should I treat Helicobacter pylori?

H pylori Positive

H pylori Negative

ASYMPTOMATIC post-HP treatment

Treat H pylori

If H pylori negative treat as functional dyspepsia. Step down to lowest dose of PPI or H 2 RA needed to control symptoms. Review annually, including PPI need.

Reassure, as negative predictive value (NPV) of all tests is >95%

Only retest for HP if DU, GU, family history of cancer, MALToma or if test was performed within two weeks of PPI or four weeks of antibiotics

When should I test for Helicobacter pylori (HP)?

When is a test for Helicobacter pylori not required?

Approved by AMG July 2019

  • Eradication therapy is much more likely to succeed if the patient fully understands the reason for their treatment and is given full information and counselling to encourage excellent adherence.
  • Macrolide and quinolone resistance is an important risk factor for treatment failure. Metronidazole or tetracycline resistance is less important.
  • To reduce the emergence of resistance and Clostridioides difficile infection (CDI), avoid levofloxacin regimes unless no other options available.
  • Doses detailed below assume non pregnant adults with normal renal and hepatic function.
  • If post gastro-duodenal bleed, only start HP treatment when patient can take oral medication
  • If diarrhoea develops, consider CDI and review need for treatment
    • PPI regimes as per NHS Tayside formulary/PHE 2019 (omeprazole 20mg – 40mg bd or lansoprazole 30mg bd)
  • **Consider quinolone warnings and interactions and prolonged QT with clarithromycin

NO PENICILLIN ALLERGY PENICILLIN ALLERGY

FIRST LINE: 7 days PPI bd* PLUS amoxicillin 1g bd PLUS either metronidazole 400mg bd OR clarithromycin 500mg bd**

FIRST LINE: 7 days PPI bd* PLUS metronidazole 400mg bd PLUS clarithromycin 500mg bd**

ONGOING SYMPTOMS after first line – SECOND LINE: 7 days PPI twice daily* PLUS amoxicillin 1g bd PLUS second antibiotic not used in first line, either clarithromycin 500mg bd** or metronidazole 400mg bd

FIRST LINE WITH PREVIOUS MACROLIDE EXPOSURE (in last 12 months) OR SECOND LINE WITH PREVIOUS QUINOLONE EXPOSURE (in last 12 months) : 7 days PPI twice daily* PLUS bismuth subsalicylate 525mg qds OR Tripotassium dicitratobismuthate 240mg qds PLUS tetracycline hydrochloride 500mg qds PLUS metronidazole 400mg bd ONGOING SYMPTOMS AFTER FIRST LINE AND PREVIOUS EXPOSURE TO METRONIDAZOLE AND CLARITHROMYCIN – SECOND LINE: 7 days PPI bd* PLUS amoxicillin 1g bd PLUS tetracycline 500mg qds OR levofloxacin** 250mg bd

ONGOING SYMTOMS AFTER FIRST LINE AND NO PREVIOUS EXPOSURE TO

LEVOFLOXACIN: 7 days PPI bd* PLUS metronidazole 400mg bd PLUS levofloxacin**250mg bd

THIRD LINE: Only offer longer duration or third line therapy on advice from specialist

How should I treat Helicobacter pylori?

Approved by AMG July 2019

NICE CG184. Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management. Updated November 2014.

O’Connor A et al. Treatment of Helicobacter pylori in infection 2010. Helicobacter 2010 Sept;15 Suppl 1:46-52.

Tayside Area Formulary

ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. Am J Gastroenterol 2017;112:212-238.

Approved by AMG July 2019